Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma
about
Identification of differentially expressed microRNAs in human male breast cancerDiscovery pipeline for epigenetically deregulated miRNAs in cancer: integration of primary miRNA transcriptionClinical outcome prediction by microRNAs in human cancer: a systematic reviewEpigenetic regulation of miR-184 by MBD1 governs neural stem cell proliferation and differentiationmiRNAs in human cancerMicroRNA-182-5p targets a network of genes involved in DNA repairDysregulation and functional roles of miR-183-96-182 cluster in cancer cell proliferation, invasion and metastasisMicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate CancerPSA and beyond: alternative prostate cancer biomarkersPrognostic role of microRNA-145 in prostate cancer: A systems review and meta-analysisRoles of miR-182 in sensory organ development and cancerThe Emerging Role of miRNAs in HTLV-1 Infection and ATLL PathogenesisExtracellular microRNAs in urologic malignancies: chances and challengesClinical and pathological implications of miRNA in bladder cancerNovel RNA markers in prostate cancer: functional considerations and clinical translationMicroRNA-183 Family in Inner Ear: Hair Cell Development and Deafness.The microRNA-183 cluster: the family that plays together stays togetherPrognostic role of microRNA-205 in multiple human malignant neoplasms: a meta-analysis of 17 studiesMiR-96 downregulates REV1 and RAD51 to promote cellular sensitivity to cisplatin and PARP inhibitionMicroRNA-200c and microRNA-31 regulate proliferation, colony formation, migration and invasion in serous ovarian cancerAn integrated transcriptome and epigenome analysis identifies a novel candidate gene for pancreatic cancerThe antiapoptotic function of miR-96 in prostate cancer by inhibition of FOXO1Identification of miRs-143 and -145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMTmiR-182, of the miR-183 cluster family, is packaged in exosomes and is detected in human exosomes from serum, breast cells and prostate cellsmiRNAs associated with prostate cancer risk and progressionMicroRNA as new tools for prostate cancer risk assessment and therapeutic intervention: results from clinical data set and patients' samplesDistinct microRNA expression profile in prostate cancer patients with early clinical failure and the impact of let-7 as prognostic marker in high-risk prostate cancerGlobal analysis of the differentially expressed miRNAs of prostate cancer in Chinese patientsArtesunate suppresses the viability and mobility of prostate cancer cells through UCA1, the sponge of miR-184miR-125b induces cellular senescence in malignant melanoma.Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer.A networks method for ranking microRNA dysregulation in cancer.Development of the human cancer microRNA network.Widespread microRNA dysregulation in multiple system atrophy - disease-related alteration in miR-96.MiR-205 inhibits cell apoptosis by targeting phosphatase and tensin homolog deleted on chromosome ten in endometrial cancer Ishikawa cells.MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer.Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy.Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer.MicroRNA expression signatures of bladder cancer revealed by deep sequencing.A novel computational framework for simultaneous integration of multiple types of genomic data to identify microRNA-gene regulatory modules
P2860
Q21261330-8DFEC18A-6E51-4D85-8ACB-269A877B34C4Q21267171-32574AE6-667D-4844-9F6E-4A8E4B4E1BB0Q24289183-485F34C9-B8E1-44AD-88D6-8B2BA894DE55Q24621879-9066125B-2918-4272-B94F-5303FA651D58Q24628889-DEE0E874-ACE7-4422-A2EB-194F87C12656Q24633326-FD5285D5-0E60-4626-A5EE-0ADE31DC9DCAQ26747871-2038A60B-5579-4DC2-B6B2-21B933875622Q26751983-29476CD1-8C68-4990-9A5A-6684EC81344DQ26770646-7F0CB201-DA8F-41A0-B828-CD003BA0AA28Q26782530-FDF4D419-3096-458A-A11E-369637E4BF72Q26798264-736BDD67-6176-4B88-8CDD-C086635DB959Q26800055-9A654302-DB0F-4551-B10B-20B83E6E1B3EQ26866043-12FA84B2-9857-434F-A854-A80F1554C720Q27004262-6F7EA436-C52D-4B8A-9CC0-7600DB63D0E8Q27021174-C1C7380B-4D06-46C9-9803-8FF2B2183106Q28076427-AB721172-1CD0-46A7-A5EE-0D43C2DE94C6Q28080473-9632BFD4-51DE-45EF-86EB-1C7BC118F464Q28084872-B2AA0E6E-DCBA-4411-BBE1-592F16BBFFE6Q28270311-2AA5CCCD-E605-4C86-95D2-33C560FFF931Q28385520-E46479AB-6882-4912-B35C-03D9F11D54DAQ28392205-28799832-4C97-4A74-9F59-386472C2192EQ28535282-AA88B778-9D63-470E-8A5A-ED268F1B1F4CQ28744173-0FBE5799-F90B-4469-A3CC-96B6740CA5D2Q28829628-434A7225-DB4F-4AA2-AC8B-E168F99E9A24Q30235186-6BD19C59-F157-44E7-811E-335A5705E862Q30859743-2CE0682F-9E3B-4A22-82A1-C3941943F4F3Q31119968-EF2B5219-3C96-4673-B9AC-9C777E1DE70BQ33559632-3779ECD0-A0BE-4BBD-AE51-E62F95B5C0E2Q33566906-1990DEAF-0E90-448B-ABE9-AAAAE2F47320Q33613408-0F60B9A9-4B7E-440E-AFE4-C557FAFF9E93Q33613644-EA123C1F-F021-4181-A386-B50D2A5A73A5Q33641704-2FEAEE12-3AEA-44EA-8B9C-AD19B2EB62C6Q33717233-70D6C79C-0500-456E-AE4E-9CEF96FA32C7Q33738316-B522A73F-4181-4569-A83B-286A6EB6FEDCQ33815178-B5AA923A-8936-4B44-93C5-DD727B875559Q33829462-4EE601E0-B731-4891-B911-0F8B374CCDABQ33834711-2145A809-6193-4130-BE79-237610610732Q33837404-4E7F3492-AB5E-4C3C-8ADB-FA82ADFAFFDEQ33862587-B288668F-E103-4E1F-AD4D-CF68BEFC9B41Q33936112-95DC539F-A828-48BE-8BB7-B5EE584B80F4
P2860
Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma
@ast
Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma
@en
Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma
@nl
type
label
Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma
@ast
Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma
@en
Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma
@nl
prefLabel
Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma
@ast
Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma
@en
Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma
@nl
P2093
P3181
P356
P1476
Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma
@en
P2093
Carsten Stephan
Florian Jentzmik
Glen Kristiansen
Ina Wagner
Klaus Jung
Kurt Miller
Michael Lein
Monika Jung
P304
P3181
P356
10.1002/IJC.24827
P407
P577
2010-03-01T00:00:00Z